Subgroup identification-based model selection to improve the predictive performance of individualized dosing

Ewoldt TMJ, Abdulla A, Rietdijk WJR et al (2022) Model-informed precision dosing of beta-lactam antibiotics and ciprofloxacin in critically ill patients: a multicentre randomised clinical trial. Intensive Care Med 48:1760–1771. https://doi.org/10.1007/S00134-022-06921-9

Article  CAS  PubMed  PubMed Central  Google Scholar 

Neely MN, Kato L, Youn G et al (2018) Prospective trial on the Use of Trough Concentration versus Area under the curve to determine therapeutic vancomycin dosing. Antimicrob Agents Chemother 62. https://doi.org/10.1128/AAC.02042-17

Roggeveen LF, Guo T, Fleuren LM et al (2022) Right dose, right now: bedside, real-time, data-driven, and personalised antibiotic dosing in critically ill patients with sepsis or septic shock—a two-centre randomised clinical trial. Crit Care 26:1–11. https://doi.org/10.1186/S13054-022-04098-7/TABLES/4

Article  Google Scholar 

Frymoyer A, Schwenk HT, Zorn Y et al (2020) Model-informed Precision Dosing of Vancomycin in Hospitalized Children: implementation and adoption at an academic children’s hospital. Front Pharmacol 11:551. https://doi.org/10.3389/FPHAR.2020.00551/BIBTEX

Article  CAS  PubMed  PubMed Central  Google Scholar 

He N, Su S, Yan Y et al (2020) The benefit of Individualized Vancomycin Dosing Via Pharmacokinetic Tools: a systematic review and Meta-analysis. Ann Pharmacother 54:331–343. https://doi.org/10.1177/1060028019887363/ASSET/IMAGES/LARGE/10.1177_1060028019887363-FIG4.JPEG

Article  PubMed  Google Scholar 

Sanz-Codina M, Bozkir HÖ, Jorda A, Zeitlinger M (2023) Individualized antimicrobial dose optimization: a systematic review and meta-analysis of randomized controlled trials. Clin Microbiol Infect. https://doi.org/10.1016/J.CMI.2023.03.018

Article  PubMed  Google Scholar 

Kalamees R, Soeorg H, Metsvaht T, Lutsar I (2023) Prospective validation of model-informed precision dosing of vancomycin in neonates and infants. In: The 41st Annual Meeting of the European Society for Paediatric Infectious Diseases

Roggeveen LF, Fleuren LM, Guo T et al (2019) Right dose right now: bedside data-driven personalized antibiotic dosing in severe sepsis and septic shock - rationale and design of a multicenter randomized controlled superiority trial. Trials 20. https://doi.org/10.1186/S13063-019-3911-5

Stanski NL, Wong HR (2019) Prognostic and predictive enrichment in sepsis. Nature Reviews Nephrology 2019 16:1 16:20–31. https://doi.org/10.1038/s41581-019-0199-3

Uster DW, Stocker SL, Carland JE et al (2021) A Model Averaging/Selection Approach improves the predictive performance of Model-Informed Precision Dosing: Vancomycin as a case study. Clin Pharmacol Ther 109:175–183. https://doi.org/10.1002/CPT.2065

Article  CAS  PubMed  Google Scholar 

Tang BH, Guan Z, Allegaert K et al (2021) Drug Clearance in neonates: a combination of Population Pharmacokinetic Modelling and Machine Learning approaches to improve individual prediction. Clin Pharmacokinet 60:1435–1448. https://doi.org/10.1007/S40262-021-01033-X/TABLES/5

Article  CAS  PubMed  Google Scholar 

Chan A, Peck R, Gibbs M, van der Schaar M (2023) Synthetic model combination: a new machine-learning method for pharmacometric model ensembling. CPT Pharmacometrics Syst Pharmacol 12:953–962. https://doi.org/10.1002/PSP4.12965

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tasa T, Metsvaht T, Kalamees R et al (2017) DosOpt: a tool for personalized bayesian dose adjustment of Vancomycin in neonates. Ther Drug Monit 39:604–613. https://doi.org/10.1097/FTD.0000000000000456

Article  CAS  PubMed  Google Scholar 

Gastmans H, Dreesen E, Wicha SG et al (2022) Systematic comparison of hospital-wide Standard and Model-based therapeutic drug monitoring of vancomycin in adults. Pharmaceutics 14:1459. https://doi.org/10.3390/PHARMACEUTICS14071459/S1

Article  CAS  PubMed  PubMed Central  Google Scholar 

Steinbach M, Ertöz L, Kumar V (2004) The challenges of Clustering High Dimensional Data. New Dir Stat Phys 273–309. https://doi.org/10.1007/978-3-662-08968-2_16

Mannor S, Jin X, Han J et al (2011) K-Medoids clustering. Encyclopedia Mach Learn 564–565. https://doi.org/10.1007/978-0-387-30164-8_426

Zhu Y, Li C, Dunson DB (2021) Classification trees for Imbalanced Data: surface-to-volume regularization. J Am Stat Assoc. https://doi.org/10.1080/01621459.2021.2005609/SUPPL_FILE/UASA_A_2005609_SM9089.PDF

Article  PubMed  PubMed Central  Google Scholar 

Jollife IT, Cadima J (2016) Principal component analysis: a review and recent developments. Philosophical Trans Royal Soc A: Math Phys Eng Sci 374. https://doi.org/10.1098/RSTA.2015.0202

Hand DJ (2006) Classifier technology and the illusion of progress. Stat Sci 21:1–14. https://doi.org/10.1214/088342306000000060

Article  MathSciNet  Google Scholar 

Ismail M, Sale M, Yu Y et al (2022) Development of a genetic algorithm and NONMEM workbench for automating and improving population pharmacokinetic/pharmacodynamic model selection. J Pharmacokinet Pharmacodyn 49:243–256. https://doi.org/10.1007/S10928-021-09782-9/TABLES/1

Article  CAS  PubMed  Google Scholar 

Zhao W, Lopez E, Biran V et al (2013) Vancomycin continuous infusion in neonates: dosing optimisation and therapeutic drug monitoring. Arch Dis Child 98:449–453. https://doi.org/10.1136/ARCHDISCHILD-2012-302765

Article  PubMed  Google Scholar 

Mehrotra N, Tang L, Phelps SJ, Meibohm B (2012) Evaluation of Vancomycin Dosing regimens in Preterm and Term neonates using Monte Carlo simulations. Pharmacotherapy: J Hum Pharmacol Drug Therapy 32:408–419. https://doi.org/10.1002/J.1875-9114.2012.01029.X

Article  CAS  Google Scholar 

Jacqz-Aigrain E, Leroux S, Thomson AH et al (2019) Population pharmacokinetic meta-analysis of individual data to design the first randomized efficacy trial of Vancomycin in neonates and young infants. J Antimicrob Chemother 74:2128–2138. https://doi.org/10.1093/JAC/DKZ158

Article  CAS  PubMed  Google Scholar 

De Cock RFW, Allegaert K, Sherwin CMT et al (2014) A neonatal amikacin covariate model can be used to predict ontogeny of other drugs eliminated through glomerular filtration in neonates. Pharm Res 31:754–767. https://doi.org/10.1007/S11095-013-1197-Y

Article  PubMed  Google Scholar 

Oudin C, Vialet R, Boulamery A et al (2011) Vancomycin prescription in neonates and young infants: toward a simplified dosage. Arch Dis Child Fetal Neonatal Ed 96:F365–F370. https://doi.org/10.1136/ADC.2010.196402

Article  CAS  PubMed  Google Scholar 

Colin PJ, Allegaert K, Thomson AH et al (2019) Vancomycin Pharmacokinetics throughout Life: results from a Pooled Population analysis and evaluation of current dosing recommendations. Clin Pharmacokinet 58:767–780. https://doi.org/10.1007/S40262-018-0727-5/TABLES/5

Article  CAS  PubMed  Google Scholar 

Tang Z, Guan J, Li J et al (2021) Determination of Vancomycin exposure target and individualised dosing recommendations for neonates: model-informed precision dosing. Int J Antimicrob Agents 57:106300. https://doi.org/10.1016/J.IJANTIMICAG.2021.106300

Article  CAS  PubMed  Google Scholar 

Song L, He C-Y, Yin N-G et al (2017) A population pharmacokinetic model for individualised dosage regimens of Vancomycin in Chinese neonates and young infants. Oncotarget 8:105211–105221. https://doi.org/10.18632/ONCOTARGET.22114

Article  PubMed  PubMed Central  Google Scholar 

Hughes JH, Tong DMH, Lucas SS et al (2021) Continuous learning in Model-Informed Precision Dosing: a Case Study in Pediatric Dosing of Vancomycin. Clin Pharmacol Ther 109:233–242. https://doi.org/10.1002/CPT.2088

Article  CAS  PubMed  Google Scholar 

Cunio CB, Uster DW, Carland JE et al (2021) Towards precision dosing of Vancomycin in critically ill patients: an evaluation of the predictive performance of pharmacometric models in ICU patients. Clin Microbiol Infect 27. https://doi.org/10.1016/J.CMI.2020.07.005. :783.e7-783.e14

Dhaese SAM, Farkas A, Colin P et al (2019) Population pharmacokinetics and evaluation of the predictive performance of pharmacokinetic models in critically ill patients receiving continuous infusion meropenem: a comparison of eight pharmacokinetic models. J Antimicrob Chemother 74:432–441. https://doi.org/10.1093/JAC/DKY434

Article  CAS  PubMed  Google Scholar 

Cella M, Knibbe C, de Wildt SN et al (2012) Scaling of pharmacokinetics across paediatric populations: the lack of interpolative power of allometric models. Br J Clin Pharmacol 74:525–535. https://doi.org/10.1111/J.1365-2125.2012.04206.X

Article  PubMed  PubMed Central  Google Scholar 

Loftus TJ, Shickel B, Balch JA et al (2022) Phenotype clustering in health care: a narrative review for clinicians. Front Artif Intell 5:184. https://doi.org/10.3389/FRAI.2022.842306/BIBTEX

Article  Google Scholar 

Gous AGS, Dance MD, Lipman J et al (1995) Changes in Vancomycin Pharmacokinetics in critically ill infants. 23:678–682. https://doi.org/101177/0310057X9502300603

Mørk ML, Andersen JT, Lausten-Thomsen U, Gade C (2022) The blind spot of Pharmacology: a scoping review of drug metabolism in prematurely born children. Front Pharmacol 13:351. https://doi.org/10.3389/FPHAR.2022.828010/BIBTEX

Article  Google Scholar 

Rios DR, Rhee CJ, Elizondo L et al (2020) Creatinine filtration kinetics in critically ill neonates. Pediatr Res 2020 89(4):952–957. https://doi.org/10.1038/s41390-020-0977-4

Article  CAS  Google Scholar 

Broeker A, Nardecchia M, Klinker KP et al (2019) Towards precision dosing of Vancomycin: a systematic evaluation of pharmacometric models for bayesian forecasting. Clin Microbiol Infect 25. https://doi.org/10.1016/J.CMI.2019.02.029. :1286.e1-1286.e7

Ackerman M, Ben-David S, Brânzei S, Loker D (2021) Weighted clustering: towards solving the user’s dilemma. Pattern Recognit 120:108152. https://doi.org/10.1016/J.PATCOG.2021.108152

Article  Google Scholar 

Pierre-Jean M, Deleuze JF, Le Floch E, Mauger F (2020) Clustering and variable selection evaluation of 13 unsupervised methods for multi-omics data integration. Brief Bioinform 21:2011–2030. https://doi.org/10.1093/BIB/BBZ138

Article  CAS  PubMed  Google Scholar 

Cabitza F, Campagner A, Soares F et al (2021) The importance of being external. Methodological insights for the external validation of machine learning models in medicine. Comput Methods Programs Biomed 208:106288. https://doi.org/10.1016/J.CMPB.2021.106288

Article  PubMed  Google Scholar 

El Hassani M, Marsot A (2023) External evaluation of Population Pharmacokinetic models for Precision Dosing: current state and knowledge gaps. Clin Pharmacokinet 62:533–540. https://doi.org/10.1007/S40262-023-01233-7

Article  PubMed 

留言 (0)

沒有登入
gif